Video

Some Doctors Prescribe Antibiotics Because Parents Want Them

What Kids Wear Could Determine How Much Exercise They Get

Few College Students Have Received the H1N1 Vaccine

Night Lights Could Lead to Depression

Cervarix Has Been Approved by the FDA

The FDA Is Studying the Effects of Lasik Surgery

Painkillers Can Dull the Effects of Childhood Vaccines

Childbirth May Becoming More Complicated

Botox Sponges Might Help Nose Allergies

The FDA Advises on How to Properly Dispose of Medicine

A French Study Shows Cell Phones Do Not Affect Humans

MRIs May Lead to More Back Surgery

Your More Likely to Wash Your Hands If Someone's Watching

Co-Sleeping Is a Leading Cause of SIDS

Night Shifts Don't Have a Major Effect On Surgeons

New Target Eyed for Colon Cancer Drugs

Posted on 08/18/2009, 16:00
By -- Robert Preidt

In mouse study, researchers see possibility of 'potent therapy'

TUESDAY, Aug. 18 (HealthDay News) -- Drugs that target a cell surface molecule called ERBB3 could offer a more effective way to treat colon cancer, a new study suggests.

Currently, drugs that target the epidermal growth factor receptor (EGFR) are used to treat a number of cancers, but these drugs haven't proven very effective against colon cancer. ERBB3 is closely related to EGFR. Drugs aimed at ERBB3 may be much more effective than EGFR inhibitors at treating colon cancer.

In this study, researchers genetically blocked ERBB3 in mice with colon cancer and in human colon cancer cells.

"If you genetically remove ERBB3, as you would if you were pharmacologically targeting it, then the mice rarely develop colon cancer," lead author David Threadgill, adjunct professor in the department of genetics at the University of North Carolina at Chapel Hill and a professor in the genetics department at North Carolina State University, said in a news release.

He and his colleagues also found a dramatic increase in cell death when ERBB3 was genetically removed from human colon cancer cell lines.

"If we can use an inhibitor to block ERBB3, then it should be a very potent anti-cancer therapy," Threadgill said.

The study appeared online Aug. 17 in the Journal of Clinical Investigation.

More information

The U.S. National Cancer Institute has more about colon cancer treatment.

SOURCE: University of North Carolina at Chapel Hill, news release, Aug. 17, 2009

More news in Colon Cancer...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 3.0 / 5 (53 votes)